tiprankstipranks
Trending News
More News >
Cytokinetics (CH:KK3A)
:KK3A
Switzerland Market

Cytokinetics (KK3A) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

KK3A Analyst Ratings

Strong Buy
20Ratings
18 Buy
2 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Cytokinetics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KK3A Stock 12 Month Forecast

Average Price Target

$64.11
Based on 20 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $64.11 with a high forecast of $100.65 and a low forecast of $34.39. The average price target represents a change from the last price of .
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
Highest Price Target$100.65Average Price Target$64.11Lowest Price Target$34.39
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley
CHF55.75CHF54.08
Buy
Reiterated
05/08/25
Evercore ISI
CHF54.08CHF49.92
Buy
Reiterated
05/07/25
Barclays
CHF45.76CHF44.1
Buy
Reiterated
05/07/25
Needham
CHF59.91
Buy
Reiterated
05/07/25
Piper Sandler
CHF89.03
Buy
Reiterated
05/07/25
Truist Financial
Buy
Reiterated
05/07/25
Leerink Partners
CHF55.75CHF47.43
Buy
Reiterated
05/07/25
Citizens JMP
CHF64.9
Buy
Reiterated
05/07/25
Bank of America Securities
CHF41.6CHF37.44
Hold
Reiterated
05/06/25
Citi
CHF71.56CHF66.56
Buy
Reiterated
05/06/25
RBC Capital
CHF68.23CHF66.56
Buy
Reiterated
05/06/25
H.C. Wainwright
CHF99.85
Buy
Reiterated
05/06/25
Stifel Nicolaus
CHF72.39
Buy
Reiterated
05/02/25
UBS
CHF39.11CHF34.11
Hold
Reiterated
05/02/25
J.P. Morgan
CHF59.08
Buy
Reiterated
04/28/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley
CHF55.75CHF54.08
Buy
Reiterated
05/08/25
Evercore ISI
CHF54.08CHF49.92
Buy
Reiterated
05/07/25
Barclays
CHF45.76CHF44.1
Buy
Reiterated
05/07/25
Needham
CHF59.91
Buy
Reiterated
05/07/25
Piper Sandler
CHF89.03
Buy
Reiterated
05/07/25
Truist Financial
Buy
Reiterated
05/07/25
Leerink Partners
CHF55.75CHF47.43
Buy
Reiterated
05/07/25
Citizens JMP
CHF64.9
Buy
Reiterated
05/07/25
Bank of America Securities
CHF41.6CHF37.44
Hold
Reiterated
05/06/25
Citi
CHF71.56CHF66.56
Buy
Reiterated
05/06/25
RBC Capital
CHF68.23CHF66.56
Buy
Reiterated
05/06/25
H.C. Wainwright
CHF99.85
Buy
Reiterated
05/06/25
Stifel Nicolaus
CHF72.39
Buy
Reiterated
05/02/25
UBS
CHF39.11CHF34.11
Hold
Reiterated
05/02/25
J.P. Morgan
CHF59.08
Buy
Reiterated
04/28/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cytokinetics

Which Analyst Should I Follow If I Want to Buy CH:KK3A and Sell After:
1 Month
xxx
Success Rate
26/49 ratings generated profit
53%
Average Return
+4.44%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.06% of your transactions generating a profit, with an average return of +4.44% per trade.
3 Months
xxx
Success Rate
10/19 ratings generated profit
53%
Average Return
+12.07%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +12.07% per trade.
1 Year
Salim SyedMizuho Securities
Success Rate
30/49 ratings generated profit
61%
Average Return
+26.03%
reiterated a buy rating 2 months ago
Copying Salim Syed's trades and holding each position for 1 Year would result in 61.22% of your transactions generating a profit, with an average return of +26.03% per trade.
2 Years
xxx
Success Rate
33/49 ratings generated profit
67%
Average Return
+26.33%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 67.35% of your transactions generating a profit, with an average return of +26.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KK3A Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
18
27
31
38
37
Buy
14
10
9
11
10
Hold
7
4
3
5
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
39
41
43
54
54
In the current month, KK3A has received 47 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. KK3A average Analyst price target in the past 3 months is 64.11.
Each month's total comprises the sum of three months' worth of ratings.

KK3A Financial Forecast

KK3A Earnings Forecast

Next quarter’s earnings estimate for KK3A is -$1.20 with a range of -$1.35 to -$1.05. The previous quarter’s EPS was -$1.15. KK3A beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year KK3A has Outperformed its overall industry.
Next quarter’s earnings estimate for KK3A is -$1.20 with a range of -$1.35 to -$1.05. The previous quarter’s EPS was -$1.15. KK3A beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 45.45% of the time in the same period. In the last calendar year KK3A has Outperformed its overall industry.

KK3A Sales Forecast

Next quarter’s sales forecast for KK3A is $1.55M with a range of $0.00 to $12.65M. The previous quarter’s sales results were ―. KK3A beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 59.02% of the time in the same period. In the last calendar year KK3A has Outperformed its overall industry.
Next quarter’s sales forecast for KK3A is $1.55M with a range of $0.00 to $12.65M. The previous quarter’s sales results were ―. KK3A beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 59.02% of the time in the same period. In the last calendar year KK3A has Outperformed its overall industry.

KK3A Stock Forecast FAQ

What is CH:KK3A’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytokinetics’s 12-month average price target is 64.11.
    What is CH:KK3A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:KK3A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Cytokinetics a Buy, Sell or Hold?
        Cytokinetics has a consensus rating of Strong Buy, which is based on 18 buy ratings, 2 hold ratings and 0 sell ratings.
          What is Cytokinetics’s share price target?
          The average share price target for Cytokinetics is 64.11. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $100.65 ,and the lowest forecast is $34.39. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Cytokinetics?
            Cytokinetics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
              How can I buy shares of Cytokinetics?
              To buy shares of CH:KK3A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis